A non-ceruloplasmin ferroxidase (ferroxidase-II) protein was isolated from human serum and completely resolved from ceruloplasmin by DEAE-Sephadex A-50 chromatography. This protein was isolated and purified approximately 500-fold by utilization of the Cohn IV-1 fraction, DEAE-Sephadex A-50 chromatography, and gel filtration on Agarose A-15m, followed by gel filtration on Agarose A-50m. Ferroxidase-II differed from ceruloplasmin in many respects. Three of the most important differences were that ferroxidase-II (a) was yellow rather than blue as ceruloplasmin, (b) it was not inhibited by azide, and (c) it exhibited no p-phenylenediamine oxidase activity. Ferroxidase-II also differed significantly from the known plasma amine oxidases. The ferroxidase activity of ferroxidase-II was not lost by dialysis or ultrafiltration, but was inactivated by heat treatment and was proportional to the protein concentration at all stages of purification. Oxygen consumption with ferroxidase-II was observed simultaneously with iron oxidation. The ferroxidase-II activity in Wilson's disease serum represented a much larger percentage of the total ferroxidase activity than in normal serum. Although ferroxidase-II was decreased in Wilson's disease serum, it was reduced to a lesser extent than the ceruloplasmin ferroxidase activity. Thus ferroxidase-II may account for the lack of correlation of ferroxidase activity with p-phenylenediamine oxidase activity of Wilson's disease serum and may be responsible for the maintenance of near normal iron metabolism despite the low levels of ceruloplasmin.
No takes yet. Share an insight, caveat, or question.
Topham et al. (1970) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: